Johannes Jacob Pieter Kastelein New Amsterdam Pharma CO N.V. (NAMS) insider trading activity
Shares Held (Direct Ownership)
79.5K
133.77%
3M change
n/a
12M change
Total Value Held
N/A
Johannes Jacob Pieter Kastelein Transaction History
JJP
Johannes Jacob Pieter Kastelein
Chief Scientific Officer
Naarden, P7